KRAS and lung carcinoma: In 2018, Wu et al. [59] used CRISPR/Cas9 to explore tumor suppressor genes in a Kras-G12D mouse model and found that the absence of the epigenetic regulatory factor Utx significantly accelerated lung cancer progression.